esic e-tender for rate contract for testing of drugs (allopathic)- … · contract awarded after...

e-Tender Enquiry No.: 172/U-16/27/1/18/Allopathic drug testing tender/ESIC MH CHD

1

ESIC

E-Tender for Rate Contract for Testing of Drugs (Allopathic)- Part I

ESIC MODEL HOSPITAL, INDUSTRIAL AREA PH-II, RAMDARABAR, CHANDIGARH-

160002

Phone No.-0172-2639641 & 2639643, Fax- 0172-2639642

(Tender form is non-transferable)

LAST DATE OF SUBMISSION OF E-TENDER 01/03/2019.


2

IMPORTANT INSTRUCTIONS FOR BIDDERS REGARDING ONLINE PAYMENT

All bidders/contractors are required to procure class IIIB digital Signature Certificate (DSC) with

both DSC components i.e. signing and encryption to participate in the E-tenders.

Bidders should get registered at https://esictenders.eproc.in.

Bidders should add the below mentioned sites under Internet Explorer → Tools → Internet Options

→

Security → Trusted Sites → Sites of Internet Explorer :

https://esictenders.eproc.in

https://www.tpsl-india.in

https://www4.jpg-online.com

Also , Bidders need to select “Use TLS 1.1 and Use TLS 1.2” under Internet Explorer → Tools →

Internet Options → Advanced Tab → Security.

Bidder needs to submit Bid processing Fee charges of Rs.2495/-(Non Refundable) in favour of M/S C1

India Pvt. Ltd. Payable at New Delhi via Online Payment Modes such as Debit Card, Credit Card or

NetBanking for participating in the tender.

Bidders can contact our Helpdesk at https://esictenders.eproc.in/html/Support.asp


3

CONTENTS

Sr.No. Headings Page No.

1. E-Tender enquiry

1-29

2. E tender schedule 4

3. Formation of ESIC RATE CONTRACT

5

4. Instruction to Bidders

6-9

5. Conditions of Contract

10-19

6. Affidavit of the Laboratory (Annexure-A)

20-23

7. Personnel in QC Department and list of important

equipment/Instruments/Apparatus available in

laboratory and facilities in Microbiology(Annexure-B)

24

8. Mandate Form (Annexure-C)

25

9. Lowest Rate Certificate (Annexure-D)

26

10. Price Bid (Annexure-E)

27

11. Checklist of the Documents (Annexure-F)

28-29

12. List of drugs for testing (Annexure- G)

30-50

CHD


4

E-TENDER SCHEDULE

Validity of NIT – 90 Days from date of publishing of NIT

Sr.No. Details Dates & time

1. Period of online availability of E-

Tender document on www.esic.nic.in,

CPP Portal www.eprocure.gov.in and

https://esictenders.eproc.in

08.02.2019 to 01.03.2019 upto 1.00PM

2. Pre-bid meeting 15.02.2019 at 2:30 PM

Conference Hall, ESIC MH CHD,

Ind Area, Ph-II, Ramdarbar, Chandigarh.

3. Last date of Online Technical Bid

submission

01.03.2019 up to 1.00PM

4. Last date of Manual submission of

sealed envelope

01.03.2019 up to 1.00PM

5. Date of Opening of Online Technical

Bid and Tender Box

01.03.2019 at 2.30PM



6. Opening of Online Price Bid of

technically qualified bidders

Date and time to be intimated later



The tender document containing eligibility criterion, scope of work, terms & conditions etc.

are available online on:

1. https://esictenders.eproc.in

2. https://eprocure.gov.in

3. www.esic.nic.in

If the date of opening of tenders is declared a public holiday, the tenders shall be opened on

the next working day at the same venue and time.

(i) EMD as original Demand Draft of Rs.5,000/- (Rupees Five Thousand only) from any

Nationalized Bank/Scheduled Bank in favour of ‘ESIC Fund Account No.1’ payable at

Chandigarh.

(ii) Performance Security of Rs. 25,000/- (Rupees Twenty Five thousand only) in the form of

Demand Draft issued by any Nationalized Bank/Scheduled Bank.

(iii) EMD of successful bidder will be adjusted towards Performance Security.

(iv) Bids received without EMD will be summarily rejected.

All the pages of the tender should be signed by the owner of theagencies/firms/consultants himself or

his Authorized Signatory. In case the tender is signed by the Authorized Signatory, a copy of the

power of attorney/authorization should be enclosed along with tender.

Corrigendum/further notifications / updates (if any) will be uploaded on above mentioned websites

only.

Medical Superintendent

http://www.esic.nic.in/

http://www.eprocure.gov.in/

https://esictenders.eproc.in/

https://eprocure.gov.in/

http://www.esic.nic.in/


5

Subject: Formation of RATE CONTRACT for “Testing of Drugs(Allopathic)-Part 1” at ESIC

MODEL HOSPITAL, CHANDIGARH valid for two years from the date of finalization.

1. The Medical Superintendent, ESIC MH Chandigarh invites E- Tender under two bid system, from

NABL accredited OR Govt approved Laboratories located in Tricity

(Chandigarh/Mohali/Panchkula) , adjoining cities of Ludhiana, Baddi and, adjacent regions of

the National Capital Territory of Delhi ,Gurugram, Faridabad for formation of ESIC Rate

Contract for Testing of Allopathic Drugs at ESIC MH Chandigarh through e-procurement portal of

ESIC-https://esictenders.eproc.in validfor a period of two years. This can be further extended for

an additional year on same terms & conditions subject to performance review and consent of both

parties.

The Hard copy of following documents in a sealed envelope duly super scribed with e-Tender

ID No.-------and E-Tender enquiry No. -172/U-16/27/1/18/Allopathic drug testing tender/ESIC

MH CHD are to be submitted along with online bid submission:-

1.1 EMD as Specified in the “Instructions to Bidders”.

1.2 Affidavits/ Authorization letter as per clause 5 of Tender document.

1.3 Annexure ‘A’

1.4 Advance pre-receipt

2. E-Tender Enquiry Form can be viewed online or downloaded by the bidders from the website –

www.esic.nic.in, www.eprocure.gov.in andhttps://esictenders.eproc.in.

2.1 It is mandatory for all bidders to have valid Class III B Digital Signature Certificate (both with

signing and encryption component) from any certifying agency as per Information Technology

(IT) Act, 2000 for submitting e-bid at the ESIC e-procurement Portal https://esictenders.eproc.in.

Bidders can contact helpdesk at https://esictenders.eproc.in/html/support.asp.

2.2 Bidders should get registered at https://esictenders.eproc.in.

2.3 Final evaluation & finalization of Rate Contract will be based solely on e- bid submitted by the

bidder. It will be the sole responsibility of the bidder to scan and upload clear and legible

documents for assessment, failing which the tender will be liable for rejection.

3. ESIC Model Hospital Chandigarh intends to enter into a Running Rate Contract with Analytical

Testing Laboratories. Laboratories intending to participate in the Rate Contract should ensure

that they fulfill all the eligibility criteria as prescribed under the terms and conditions. (Bidder

should quote only for the items for which they fulfill all the eligibility criteria).

4. The Rate Contract will be governed by the Terms and Conditions enclosed with this Tender Enquiry

and no modifications/alterations are allowed in any case.

https://esictenders.eproc.in/


6

I. Instructions to Bidders

5. Signing of the tender

Individuals signing the tender or other documents connected with the bidding process must specify

whether he is signing as:-

i) A sole proprietor of the Laboratory or constituted Attorney of such sole proprietor.

ii) A partner of the Laboratory, if it be in partnership, in which case he must have authority to

refer to arbitration disputes concerning the business of the partnership/agreement or a power

of attorney.

iii) Constituted Attorney of the Laboratory if it is a company.

iv) Authorized signatory of the Laboratory.

N.B.

5.1 In case of Authorized signatory, authorization letter on the letter head of the laboratory duly signed

and stamped by proprietor needs to be submitted.The specimen signature of the authorized signatory

duly signed and stamped by proprietor should also be submitted to ESIC MH Chandigarh along with

the tender.

5.2 In case of (ii) a copy of partnership agreement attested by a Notary Public should be furnished or

affidavit on stamped paper of all the partners admitting execution of the partnership of the general

power of attorney should be furnished.

5.3 In the case of Laboratory run in partnership, where no authority to refer disputes concerning the

business of the partnership has been conferred on any partner, the documents must be signed by every

partner of the Laboratory.

5.4 A person signing the documents in the Bidding process forming part of the contract on behalf of

another shall be deemed to warrant that he has authority to sign the same and, if on enquiry it

appears that the person so signing had no authority to do so, the ESIC MH Chandigarh may

without prejudice to other civil and criminal remedy cancel the contract and hold the signatory

liable for all costs and damages.

5.5 Each and every page of the document uploaded/submitted in the bidding process should be signed and

stamped by the sole proprietor/ partner/ Constituted Attorney or authorized signatory of the

Laboratory.

6. The tender will be rejected if:-

6.1 Laboratory submits conditional tender.

6.2 All the papers are not complete.

6.3 Incorrect/false or misleading information is provided.

7 .The Item quoted will be rejected if more than one type of rates is quoted for one Item.


7

8.Tender will be under two Bid system as follows :

8.1 Technical bid (Hard Copy)

8.1.1 Technical Bid (Hard Copy) in a single sealed envelope super scribed with the e-Tender ID

No……. and e-Tender enquiry No: 172/U-16/27/1/18/Allopathic drug testing tender/ESIC MH

CHD should be dropped in the tender box kept in Administrative block, ESIC MH CHD on or

before 1.00 P.M. on 01.03.2019 containing:-

(i) EMD as original Demand Draft of Rs.5,000/- (Rupees Five Thousand only) from any

Nationalized Bank/Scheduled Bank in favour of ‘ESIC Fund Account No.1’ payable

at Chandigarh. Tender submitted without EMD will be summarily rejected.

OR

Documents in support of the exemption of EMD. Validity of this document should not

expire during the validity of Tender and during the entire duration of contract if

contract awarded after Technical and Financial bid evaluation.

(ii) Affidavit/Authorization as per clause 5 of Tender Document.

(iii) Affidavit as per Annexure ‘A’.

(iv) Advance pre-receipt affixing revenue stamp along with the full particulars of Bank details in

order to refund the EMD amount of unsuccessful bidders through ECS should be submitted.

Please note that the sealed envelope (as per para 8.1.1) should ONLY contain EMD,

Affidavit/Authorization letter, Annexure ‘A’ and Advance pre-receipt only. Any additional

documents shall be summarily rejected.

8.2 Technical Bid (Online) should contain duly signed & Stamped SCANNED copies of following

documents:-

8.2.1 EMD in original Demand Draft of Rs.5,000/- (Rupees Five Thousand only) from any

Nationalized Bank/Scheduled Bank in favour of ‘ESIC Fund Account No.1’ payable at

Chandigarh. Tender submitted without EMD will be summarily rejected.

OR

Documents in support of the exemption of EMD.Validity of this document should not

expire during the validity of Tender and during the entire duration of contract if

contract awarded after Technical and Financial bid evaluation.

8.2.2 Affidavit/ Authorization as per clause 5 of Tender Document.

8.2.3 Scanned Copies of BLANK tender document, duly signed & Stamped by sole proprietor/ partner/

Constituted Attorney orauthorized signatory of the Laboratory.

(No offer of rates to be uploaded with Technical Bid.)

8.2.4 GST registration certificate.

8.2.5 Valid License for carrying out “Testing Of Drugs & Dressings” issued from Statutory Body,

Authorized by Government of India with Approval under Drugs and Cosmetics Act, 1940 and

Rules, 1945 and amendments therein and should comply with schedule annexed therein.


8

8.2.6 Valid Accreditation for carrying out “Testing of Drugs” from NABL with scope of accreditation

or valid certificate from Competent authority of being a Government approved laboratory for

drugs testing.

8.2.7 Duly signed &stamped list of Government/Autonomous Health Institutions to which Testing of

Drugs are being provided (on Bidder’s letterhead).

8.2.8 Duly signed & stamped satisfactory performance certificate issued by Competent Authority of at

least One (01) Government/Autonomous Health Institution on the Institute’s letter head of

providing Testing services for the last two consecutive years .

8.2.9 Affidavit of the Laboratory on Non-Judicial stamp paper of Rs.100/-(As per Annexure A)

8.2.10 List of Personnel in QC(Quality Control) department and List of important

equipments/instruments/apparatus in the lab and facilities in the Microbiological section. (As

per Annexure B).

8.2.11 Mandate Form as per Annexure-C.

8.2.12 Copy of undertaking (signed and stamped by tender signing authority) that the quoted items

have not been / are not being tested for any other organization at the rates lower than being

quoted here (As per Annexure D).

8.2.13Financial report indicating the annual turnover in Testing of Drugs/dressings/vaccines etc. of

not less than Rupees Ten Lakhs per year of last three Financial years (i.e. 2015-16, 2016-17,

2017-18) duly attested by Chartered Accountant.

8.2.14 Any Other Supportive Documents.

8.2.15Advance pre-receipt affixing revenue stamp along with the full particulars of Bank details in

order to refund the EMD amount of unsuccessful bidders through ECS should be submitted.

* Incomplete Technical Bids as per checklist at Annexure F shall be summarily rejected.

The Medical Superintendent ,ESIC MH Chandigarh or her designated authority reserves the right

to inspect the facility any time before the opening of contract or any time during the validity of the

contract. Decision of the Medical Superintendent, ESIC MH Chandigarh shall be final in this

regard.

8.3 Price Bid - Online

8.3.1 Price Bid for quoted Items as per Table-I of Annexure-E should be in Rupees (Figures only).

8.3.1.1 Price should be filled only online in Figures on https://esictenders.eproc.in.

8.3.1.2 If the bidder does not want to quote price for any item/drug, that item should not be selected

because the selected item cannot be left blank or quoted NIL/ZERO. If selected item is left blank or quoted

as nil/zero, the bidder stands disqualified for that item.

8.3.1.3The Bidder should upload the Price Bid by giving the Rate of Testing Charges for the “complete

analysis of single sample” of an Item irrespective of methodology used for testing of


9

drugs.Online Price Bid of only those bidders who are found technically eligible will be

opened.

9. Pre-bid meeting

9.1 Pre-bid meeting will be held at Conference Hall, ESIC Model Hospital, Chandigarh at

2:30 PM on dated: 15.02.2019.

9.2 The objective of Pre-bid meeting is to clarify the tendering process.

10. No bid shall be accepted after the prescribed date and time of bid submission. Proof of postage

and courier shall not be considered as submission of bids.

11. Technical Bid Online will be opened as per schedule at given venue in the presence of

representative(s) of the Laboratories, having an authority letter for representation from the

Laboratories.

If the date of opening of tender is declared a public holiday, the tender shall be opened on the

next working day at the same venue and time.

12. The Medical Superintendent, ESIC MH CHD reserves the right to accept or reject any or all the

tenders at any stage without assigning any reason thereof. TheMedical Superintendent, ESIC

MH Chandigarh also reserves the right to reject any bid which is non- responsive or violating

any of the conditions/specifications without any liability to any loss whatsoever it may cause to

the bidder in the process.

13. Acceptance of tender by competent authority will be communicated by a letter of acceptance

after completion of formalities required for the formal acceptance of the tender & will be

forwarded to the bidder as soon as possible and the instructions contained in the communication

should be acted upon immediately.

14. Withdrawal of bids along with the earnest money will be allowed before the date of opening

of tenders.

15. EMD will be forfeited :-

(i). If bidder withdraws his participation after opening of Bid.

(ii). In case of non acceptance of terms & conditions of tender.

(iii). If successful bidder fails to start the work after award of contract.

(iv). If any false information is furnished by the bidder.

Medical Superintendent,

ESIC MH CHD


10

II. Conditions of Contract

1. DEFINITIONS:

In the interpretation of the contract and the general and /or special condition governing it, unless the context

otherwise requires:-

1.1.The term 'Contract’ shall mean the invitation to tender, the instructions to bidder, acceptance of the

tender schedule, particulars hereinafter defined and those general and special conditions that may be

added.

1.2.The term "Contractor" shall mean the person, firm or Company with whom the order for drug testing is

placed and shall deem to include the contractor's successor (approved by the ESIC MH Chandigarh),

representatives, heirs, executors and administrators unless excluded by the contract.

1.3.‘Contract price’ shall mean the price of tests accepted or the prices calculated in accordance with the

prices accepted by or on the behalf of the ESIC MH Chandigarh.

1.4.The term “delivery" shall mean delivery of reports by the dates specified in the acceptance of tender of

drug testing.

1.5.The term "Corporation" shall mean the “Employees State Insurance Corporation”.

1.6.The term ‘Medical Superintendent, ESI Hospital Chandigarh’ in addition also means any other officer

authorized for the time being to execute contract relating to the drug testing on behalf of the ESIC MH

Chandigarh .

1.7.The term "test" shall mean such test or tests as are prescribed by the specification or considered

necessary by the ESIC MH Chandigarh.

2. This rate enquiry is for the purpose of executing Rate Contract for Testing of Drugs (Allopathic) at ESIC

MH Chandigarh.

2.1 The rates accepted by the Medical Superintendent, ESIC MH Chandigarh shall be valid for the complete

period of contract for quantities of drugs that may be tested from time to time.

2.2 The bidder should read carefully the terms and conditions and bidder should quote only for those

items, for which they qualify as per terms & conditions of the Rate Contract and for which they have

valid authorization on the date of the tender, supported by documentary evidence.

2.3 The bidder should quote only one rate for each item Sr.No. without any variation or escalation clause.

Testing charges should be all inclusive of transportation Charges/ Freight charges / any

other charges irrespective of methodology used and exclusive of GST.

2.4GST will be paid to the laboratory upon submission of claim to the ESIC MH Chandigarh

withproof of actual payment of GST.GST will be paid after deduction of TDS on GST as persection 51 of

GST Act.

2.5If the bidder does not want to quote price for any item/drug, that item should not be selected

because the selected item cannot be left blank or quoted NIL/ZERO. If selected item is left blank or quoted

as nil/zero, the bidder stands disqualified for that item.Price bid has to be submitted with exact serial

number and item no as per drug list attached in Annexure G.


11

3. Validity of Bids

The quotations shall remain open for acceptance for 90 days (Ninety days only) from the date of

publishing of tenders. If required this office may ask for extension of validity of bid for a reasonable

period.

4. Eligibility Criteria for Bidders

Laboratories to be eligible should fulfill the following conditions:-

4.1 The Bidder/Laboratory should be continuously in the business of testing of drugs since

01/04/2015(please attach relevant documentary proof).

4.2 Bidder(s) participating in Tender must have annual turnover of not less than Rs.10,00,000/- (Rupees

Ten lakhs only)per year during last three consecutive Financial years (i.e. 2015-2016, 2016-17,

2017-2018).

4.3 Bidder(s) participating in Tender should not be blacklisted/deregistered by any Govt.

Institution/Autonomous Health Institution during the last three years.

4.4 Bidder(s) participating in Tender should not be convicted by any court of law in any matter on any

grounds as per undertaking.

4.5 Bidder(s) participating in Tender must have Valid License for Testing of Drugs/Dressings/Vaccines

etc., for Items quoted in the Tender, issued from Statutory body with Approval under Drugs and

Cosmetics Act, 1940 and Rules, 1945 and amendments thereinand should comply with schedule

annexed therein.

4.6 Family members of officers/officials working in ESIC cannot take part in this tender enquiry. This

will also apply to officers/officials who leave/retire from the services of ESI Corporation within

01(one) year of date of opening of tender.

4.7 Bidder(s) participating in Tender must have valid Documents in support of Registration of GST/GST

registration certificate.

4.8 Bidder(s) participating in Tender should have valid Accreditation for carrying out “Testing of Drugs”

from NABL with scope of accreditation or valid certificate from Competent authority of being a

Government approved laboratory for drugs testing.

4.9 Bidder(s) participating in Tender should have duly signed & stamped experience certificate by

Competent Authority of at least One (01) Government/Autonomous Health Institution on the

Institute’s letter head of providing Testing services for the last two consecutive years.

Bidders are advised to quote strictly as per eligibility mentioned above. Failure to adhere to the same

shall make the tender liable for rejection.


12

5. Bid Security (Earnest Money Deposit)

5.1 The bidder shall have to deposit Bid Security/Earnest Money of Rs.5,000/-(Rupees Five thousand

only) in the form of Demand Draft from any Nationalized Bank/Scheduled Bank in favour of

"ESIC fund Account No.1" Payable at Chandigarh failing which the tender will be rejected summarily.

OR

Documents in support of the exemption of EMD. Validity of this document should not

expireduring the validity of Tender and during the entire duration of contract if

contract awarded after Technical and Financial bid evaluation. Scanned copy of the same

is to be uploaded in Technical bid.

5.2 EMD of unsuccessful bidder(s) will be returned back at the earliest without any accrual

ofinterest after finalization of contract.

5.3 EMD of successful bidder will be adjusted towards Security Deposit after finalization

of tender.

6 Security Deposit:-

Successful bidders will be required to deposit as Security Deposit a sum of Rs. 25,000/-

(Rupees Twenty five thousand only) in the form of Demand Draft from any Nationalized

Bank/Scheduled Bank within the Stipulated period as and when informed.

6.1 EMD deposited by the successful bidders shall be adjusted towards the Security. Security Deposit

(i) shall remain valid for sixty days beyond the date of completion of all contractual obligations

(ii) of the agency including statutory obligations. The Security Deposit shall be forfeited if:

1. 6.1.1.Successful bidder fails to comply with any of the terms & conditions of the contract.

2. 6.1.2.Successful bidder is found to be implicated of indulging in any fraudulent practices or

3. is blacklisted any time during the contract.

6.1.3.If the contractor withdraws or amends withoutprior consent or impairs or derogates from

the tender in any respect within the period of validityof ratecontract including extension period.

6.1.4.If it comes to notice that information/ documentsfurnished areincorrect, false, misleading

or forged without prejudice to other right of the ESIC MH Chandigarh.

6.2 Security Deposit of successful bidder will be returned without any interest on receipt of

satisfactoryPerformance report from user departments after the expiry of the contract.

13

e-Tender Enquiry No.: 172/U-16/27/18/RC-Testing of Drugs(Allopathic)/ESIC MH CHD

7 Acceptance of the Tender

7.1 The Medical Superintendent reserves the right of accepting/rejecting the whole or any part of the tender

without assigning any reason.

7.2 The ESIC MH Chandigarh shall communicate acceptance of the quotation by a letter. The formal

acceptance of the tender will be forwarded to the successful bidder .

7.3 The instructions contained in the letter should be acted upon immediately by the bidder.

7.4 The bidder, whose tender is accepted will then send Contract Form conveying his acceptance of the

terms and conditions of tender in the prescribed format, on a notarized stamp paper of Rs.100/-to the

Medical Superintendent, ESIC MH Chandigarh.

7.5 The approval of this letter by the Medical Superintendent, ESIC MH Chandigarh will enforce

the contract and will be applicable as per law.

8. The Medical Superintendent, ESIC MH Chandigarh reserves the right to reject any or all

offers including the lowest quotation at any stage without assigning any reasons whatsoever.

9. Laboratories debarred by ESI Corporation for participation in ESI Rate Contract

need not apply.

10. Non submission of any mandatory information in e-Tender will render the bid liable for rejection.

11. Not following all the Terms & Conditions of e-Tender Enquiry, furnishing wrong information and

false documents will make the bidder ineligible and liable to be debarred/blacklisted from

participation in future ESI Rate Contracts for two years along with forfeiture of the Earnest

Money/Performance Security.

12. Bidder will have to furnish documents in support of the information given in the tender.

Original documents shall be submitted for verification as and when required.

13. In case of any attempt for cartelization by bidder(s) with a view to hike up the prices and/ or influence,

pressurize the buyer in any manner with regard to preparation of Rate Contract or any other procedure

related to Testing thereafter, Bid(s) of said bidder(s) may be rejected and the bidder(s) may be

blacklisted for a minimum period of Two Years/any other action deemed fit by competent authority

may be taken.

14. The bidder, if selected, will have to provide Testing facility directly to the ESIC MH Chandigarh.

No further subletting of the contract is permissible at any stage.

15. After the finalization of Rate contract by the Medical Superintendent, ESIC MH Chandigarh Orders for

Testing will be placed by the Deputy Medical Superintendent/Doctor In charge Medical Stores.

14


16. Samples for Testing will be given on every 15th& 30th day of every month (15th , 28th day of February)

during the currency of the contract in which the exact quantities to be tested on each occasion together.

If the above said dates are declared a public holiday, the bidder will collect samples for Testing on the

next working day at the same venue and time.

17. Samples for Testing against the contract will be accepted as long as these reach the contractor on or

before last date of the currency of the contract. Orders received during the closing days should be

complied within due course, in accordance with the contract, even though in some cases owing to

contract having expired, orders are to be executed after the expiry of the last date of contract.

18. No guarantee can be given as to the maximum number of Orders for testing that may be placed against

this Contract, but the contractor will have to provide Testing Facility as may be ordered during the

currency of the contract.

19. The rate quoted by bidder for Testing of Drugs/Dressings/Vaccines to the Corporation, shall in no event

exceed the lowest price at which the contractor provides the testing facility of identical description to

any other person(s)/ institutions during the said period of agreement. If at any time during the said

period, the contractor reduces the price of such items to any other person(s)/ institutions at a price lower

than the price chargeable under the agreement, he shall forthwith notify such reduction in Testing price

to the Medical Superintendent, ESIC MH Chandigarh and the price payable under the agreement for

such items after the date of its coming into force will be the reduced price. The approved price in Rate

Contract shall stand correspondingly reduced.

20. The price must be quoted F.O.R Destination per unit as shown in the schedule annexed and should be

inclusive of Freight Charges/Transportation Charges etc. irrespective of methodology used but exclusive

of GST. GST at prevailing rate shall be paid to the laboratory upon submission of claim and proof of

GST.

21. On no account should there be delay or refusal by bidder for drug testing. Samples fordrug testing

shall be given to the bidder as per preferencein Rate Contract, to be collected on the same day as

allotted.In case of failure to do so, the sample will be given to next higher bidderas per preference at

the risk and expense of the bidder who failed to collect the sample and the difference of the cost for

testing of drugs will be recovered accordingly.

22. Samples must be collected from Medical Store, ESIC MH Chandigarh, as per schedule and

as and when called for or as desired by competent authority of ESIC at cost and risk of the

Laboratory.

22.1.Samples will be given to authorized representatives of empanelled laboratory in person and reports will

be accepted accordingly.

22.2 Every Test Report should be on stipulated Form 39 in triplicate and should have Sr. No., Description of

Tests, Specifications and Results obtained including protocol of Test applied. In case of non-

pharmacopoeial products, the method of analysis should be mentioned in the report AND PROTOCOL

OF TEST APPLIED TO BE MENTIONED ON EACH REPORT.

22.3.“COMPLIES” or “PASS” or “WITHIN LIMIT” in the result column of the report is treated as

incomplete report ifthe result has some value, the actual value on analysis is to be reported.

Every report must have specific remarks(i.e.) Standard Quality or Not of Standard Quality.

Any ambiguity/cutting will not be accepted.

15


22.4. In case of failure of a sample, it is mandatory to inform the result immediately to the Medical

SuperintenendentESIC MH Chandigarh or her representative through E-mail. Hard copy of the

report must be sent as per prescribed protocols.

22.5.The test analysis will be carried out as per the pharmacopoeial monographs with the use of

Pharmacopoeial Reference Standards.

23. Testing reports are to be submitted within the stipulated time as specified against each item enlisted

below –

Sr.

No.

Name of the dosage form Number of days

required for

submission

oftesting report

*Quantity of drugs for

testing

01 Capsule/Granules/Powder Sachet

15 days 60 nos./ 20 nos. /20 nos.

respectively

02 Inhaler

15 days 25 nos.

03 Lotion/Syrup/Oral Drops/ Solution

15 days 12 nos.

04 Ointment

15 days 12 nos.

05 Dressings

15 days 6 nos.

06 Rotacap

15 days 60 nos.

07 Respules/Resp. Sol./Spray

15 days 25 nos./20 nos. /5 nos.

respectively

08 Tablet/Lozenges

15 days 60 nos.

09 Suppository

15 days 40 nos.

10 Injection/Dye/Sealant/Implant

25 days 40 nos./ 25 nos./ 25 nos./

25 nos. respectively

11 Eye/Ear/Nasal Drop

25 days 20 nos.

12 Intra-venous Fluids

25 days 6 nos.

16


24. Penalty Clause

24.1.If the successful bidder fails to provide the testing report within the stipulated period specified against

each drug to be tested, penalty of 5 % of the value of the order calculated at the contract rate per week

will be levied. The maximum penalty for late supply shall not exceed 10 % of the total value of the

order/orders.The cut-off date of submission of testing report shall be counted from the date of collection

of drugs from Medical Store, ESIC MH Chandigarh.If the report of drugs collected is not submitted even

after two weeks then the ESIC MH Chandigarhwill get the drug tested from the next higher bidder and

the difference of cost will be recovered from subsequent bills/security money deposit of the empanelled

laboratory who fails to give report of testing of drugs.

24.2.ESIC MH Chandigarh reserves the right to recover the cost of drug samples from any bidder who fails

to submit the drug testing report irrespective of the preference in Rate Contract.

24.3.Irregular sample collection/delivery of reports or failure to fulfill the terms of contract may entail for

closure of contract and for forfeiture of security deposit.

25. LEGAL

25.1.In case the successful bidder/Lab gives wrong/fraudulent result, which on later stage gets

challenged/gets declared as on “NOT OF STANDARD QUALITY” or otherwise by Government

laboratory or Government recognized laboratory or any other empanelled laboratory, the lab should be

liable to be penalized by forfeiture of performance Security and rate contract is deemed cancelled for a

period of not less than 02 year. Further, if any adverse reaction occurs/reported due to consumption of

such drug-all legal liabilities lies with the empanelled laboratory i.e. the empanelled laboratory will be

responsible for all kinds of damages occurring due to consumption of such drug.

25.2.If the bidder fails to deliver report of drug testing within the stipulated time and later on, drug of that

particular batch is found not of standard quality by any other laboratory and meanwhile any adverse

reaction occurs/reported due to consumption of such drug-all legal liabilities lie with the empanelled

laboratory i.e. the empanelled laboratory will be responsible for all kinds of damages occurring due to

consumption of such drug.

25.3.If the bidder fails to deliver report of drug testing at all and later on drug of that particular batch is

found not of standard quality by any other laboratory and meanwhile any adverse reaction

occurs/reported due to consumption of such drug-all legal liabilities lie with the empanelled laboratory

i.e. the empanelled laboratory will be responsible for all kinds of damages occurring due to consumption

of such drug.

26. List of Government institutes/Autonomous institutes to be provided for which testing services

are being provided by the bidder.

27. The rates should be applicable for Chandigarh(UT) at FOR.

17


28. Price Bid:-

28.1.Bidder must quote the rates strictly as per the given Format (Table-I) and as per the list of Items

attached with the tender form, mentioning the exact Serial No. and Item No.-

Table-I (Rates irrespective of methodology used )

1 2 3 4 5

Sr.No. Item No. Dosage form Name of Item Rate per Test (in

Rupees) all inclusive

except GST

28.2.EMD of those Bidder(s), who do not give acceptance for Testing of Drugs for those Items in which

they individually qualify at “Lowest Rates(L1 Rates), will be forfeited.

29. Billing & Payment

Bills to be submitted in triplicate duly signed and stamped by 10th of every month to enable timely

payment. Payment for the reports will be made within 4 to 6 weeks (after receipt and acceptance of the

Bill).

30. Subletting of contract:

The Contractor shall not sublet, transfer or assign the contract or any part thereof. In the event of the

contractor contravening this condition Medical Superintendent, ESIC MH Chandigarh will be entitled to

place the contract elsewhere at therisk of the contractors account and the contractor shall be liable for any

loss or damage that ESIC MH Chandigarh may sustain in consequence arising out of such replacing of the

contract.

31. Rate Revision :

Successful bidders shall not be entitled to any rate revision of price for any reason except that

allowed by Government of India or downward revision as mentioned in clause 19.

32.Recovery of sums due:

Whenever any claim for the payment of a sum of money arises out of or under this contract

against the contractor the purchaser shall be entitled to recover such sum by appropriating,

in part or whole from the future bills of the bidder/security deposited by the contractor.

Should this sum not be sufficient to cover the full amount recoverable, the contractor

shall pay to the ESIC MH Chandigarh on demand the remaining balance due.

18


33. Fraud & Corruption

33.1The bidder, supplier and the contractor shall observe the highest standard of ethics during

the procurement & execution of such contracts in pursuit of this:

33.2Definitions, for the purposes of this provision and the terms set forth are as follow:-

33.2.1. “Corrupt Practice” means the offering, giving, receiving or soliciting directly or indirectly

of anything of value to influence the action of public official in the procurement process or in

contract execution.

33.2.2. “Fraudulent Practice” means a misrepresentation or omission of facts in order to influence a

procurement process or the execution of a contract.

33.2.3. “Collusive Practice” means a scheme or arrangement between two or more bidders, with or

without the knowledge of the purchaser, designed to establish bid prices at artificial, non -

competitive levels;

33.2.4 “Coercive Practices” means harming or threatening to harm, directly or indirectly, person or their

property to influence their participation in the procurement process or affix to execution of a contract.

33.2.5. Will reject a proposal for award, if it is determined that the bidder recommended for award has

directly or through an agent engaged in corrupt, fraudulent, collusive, coercive practices in competing

for contract in question.

34. Arbitration

In the event of any dispute or difference arising under these conditions or any special conditions or

contract or in connection with this contract, except as to any matters the decision on which is specially

provided for by these or special conditions the same shall be referred to the sole arbitration of the

Medical Superintendent, ESIC MH Chandigarh or some other person appointed by her under the

Arbitration Act, 1996 and the rules there under and any statutory Modifications thereof for the time being

in force shall be deemed to apply to the arbitration proceedings under this clause. There shall be no

objection that the arbitrator is a Government/Corporation servant and that he had to deal with matters to

which contract relates or that in the course of his duties as Govt./ Corporation servant he had expressed

views on all or any of the arbitration dispute or differences. The award of the arbitrator shall be final and

binding on both the parties to this contract.

34.1. The venue of the arbitration shall be Chandigarh(UT).

34.2. All the disputes relating to this tender enquiry and Rate Contract shall be subject to the

territorial Jurisdiction of Courts at Chandigarh(UT) only.

34.3. In this clause the expression the Medical Superintendent, ESIC MH Chandigarh means the Medical

Superintendent, ESIC MH Chandigarh for the time being and includes, if there be no Medical

Superintendent, ESIC MH Chandigarh , the officer who is for the time being the Administrative

head of the ESIC MH Chandigarh whether in addition or otherwise.

34.4. For the purpose of the contract including proceedings there under, the Medical Superintendent,

ESIC MH Chandigarh shall be entitled to exercise all the rights and powers for the ESIC MH

Chandigarh.

19


35. Validity of the Rate Contract is two years from the date of finalization of the contract. Period can

be extended further for a period of one year more as desired by the Medical Superintendent, ESIC

MH Chandigarh with consent of both the parties.

36. Canvassing in any form is strictly prohibited and the bidders who are found canvassing are liable

to have their tenders rejected out-rightly.

37. The bidderat all times should indemnify ESIC Model Hospital, Chandigarh against all

claims, damages or compensation.

38. MSME provisions will be adhered to in this tender as per Government of India guidelines.

39. Force Majeure will be applicable to both the parties.


ESIC MH Chandigarh.

20


Annexure- “ A”

Affidavit of the Laboratory

(On Non-Judicial Stamp Paper of Rs.100/-)

From:- Name of the Laboratory/Company:

Address for correspondence:

Telephone No.:

Working Fax No.

E-mail address

Details of Person responsible for conduct of business

(Name, Mobile No. & e-mail address)

To


ESIC Model Hospital,

Industrial Area, Ph II,

Ram Darbar,

Chandigarh-160002

Sub: Quotation/s submitted for e-tender for testing of Drugs.

Sir,

I/We/am/are authorized signatories of M/s.________________________

I/ we hereby undertake as follows:-

1. I/we hereby undertake to do Testing of Drugs for a period of two years from the date of signing of

agreement at the rates quoted by me/us and offered to me/us by MS, ESIC MH Chandigarh and in the

quantities specified in the prescribed tender form, which is submitted herewith according to the

instructions and the terms and conditions. The duration of the said contract may be extended on the

same terms and conditions for an additional one year subject to performance review and consent of both

parties.

2. I/we hereby undertake that the rates quoted against each item by me/us in the tender are FOR

destination and inclusive of all freight charges, transportation charges and duties payable during the

contract period irrespective of methodology used but exclusive of GST.GST at prevailing rate shall be

paid to the laboratory upon submission of claim with proof of actual payment of GST.

21


3. I/we hereby undertake that I/we have submitted the necessary documents as required are enclosed

herewith in the order in which they are mentioned.

4. I/we understand that security deposit submitted on entering into contract, is likely to be forfeitedin the

event of lapse on my/our part to comply with the terms and conditions of the tender and/or if proven to

have followed unscrupulous practices apart from the liability of penal action for violating the law of the

land.

5. I/we have carefully read and understood the terms and conditions to avoid any error, omission. I/we

shall abide by these conditions. I/we will follow them very scrupulously. Any conditional acceptance

shall make my tender liable for rejection.

6. I/We hereby undertake that My/our Laboratory have annual turnover of not less than Rs.10,00,000/-

(Rupees Ten Lakhs only) per year during last three consecutive Financial years (i.e.2015-2016,

2016-17, 2017-2018).

7. I/We hereby undertake that My/our Laboratory is not blacklisted/deregistered currently and has not been

Blacklisted/deregistered by any other Govt. institution/ Organization during the last three years for

Testing of Drugs/Dressings/Vaccines/Other items or on any other grounds and is in this business in

continuation from year 2015. I/We further state and undertake that I/We have not been convicted byany

court of law in any matter related to Testing of Drugs/Dressings/Vaccines /Other items or on any other

grounds.

8. I/We hereby undertake that I/We have of valid accreditation from NABL for testing of drugs or valid

certificate from Competent authority of being a Government approved laboratory for drug testing.

9. I/We hereby undertake that I/We have Satisfactory performance certificate from one (01)

Government/Autonomous Institutions, duly signed & stamped by the Competent Authorityon their

letterhead of last two consecutive years .

10. I/We hereby undertake that My/our Laboratory is not convicted in an offence under the prevention of

Corruption Act,1988 (including its amendments).

11. I/We hereby undertake that My/our Laboratory is not convicted in an offence under the Indian Penal

Code or any other law for the time being in force, for any loss of life or property or causing a threat to

public health as part of execution of a public procurement/service contract.

12. I/we also undertake cognizance of the fact that failure to furnish the information as per terms and

condition of contract or non-adherence with tender terms and conditions as called for by the ESIC MH

Chandigarh or to comply with any requirements laid down under the conditions will be considered as

disqualification and shall render this tender liable for rejection.

13. I/we hereby undertake to abide by the instructions issued by the Medical Superintendent, ESIC MH

Chandigarh from time to time.

14. In case of my/our Laboratory’s Report declared wrong by any Government/ Government Approved

Agency I/We am/are liable for Appropriate Action as detailed in the tender’s terms and conditions.

22


15. I/we hereby undertake , that the rate quoted by me/us are not higher than the rate quoted by me/us to any

Govt. Institution/agency during the contract period and the quoted Items have not been & are not being

tested for any other organization at rates lower than being quoted here.

16. I/we hereby undertake that, if at any time during the currency of the contract, I/we reduce the price for

Testing of Drugs/ Dressings/Vaccines, as are covered under the contract, to any govt. organization at a

price lower than the price chargeable under the contract, I/we shall forthwith notify such reduction to the

Medical Superintendent, ESIC MH Chandigarh and the price payable under the contract for the Testing

of Drugs, after the date of coming into force of such deduction, shall stand correspondingly reduced.

17. I/We further undertake that in case of any down-ward revision same will be passed on to the ESI

Corporation from the effective date during the currency of the contract and in case of failure to do so

weare liable to be debarred from future ESIC Tenders for a period of two years along with forfeiture of

Performance security.

18. I/We hereby undertake that our Laboratory has experience for Testing of Drugs/Dressings/Vaccines of

last three financial years for the item(s) quoted in e-Tender.

19. I/We hereby undertake that I/We have Valid License for the Testing of Drugs/Dressings/Vaccines etc.

quoted in e-tender issued from Statutory Body, Authorized by Government of India with Approval under

Drugs and Cosmetics Act, 1940and Rules, 1945 and amendments therein and should comply with

schedule annexed therein.

20. I/we hereby undertake to abide by the terms and conditions of the contract modified from time to time

and I/we have signed all the papers of terms and conditions.

21. I/We hereby undertake that I/We have carefully read the Terms and Conditions of the Rate Contract and

accept the same.

22. I/We hereby undertake that our Laboratory has successfully executed all the Rate Contract/ Tender(s)

awarded to my/our Laboratory by Govt. organization(s)/institution(s) during last three years i.e. w.e.f.

April 2015 to March 2016, April 2016 to March 2017& April 2017 to March 2018 and till date.

23. I/We hereby undertake and declare that none of my/our family members is/are working in ESI

Corporation, Nor I/our family members superannuated/left/retired from the services of ESI Corporation

in the last 01(one) year from the date of opening of the tender.

24. I/we hereby undertake that if at any time, any information is found to be false, my/our tender/ Contract

is liable to be rejected at any stage by the Medical Superintendent, ESIC MH CHD without assigning

any reason along with forfeiture of Performance security.

25. I/we hereby undertake that the test analysis will be carried out as per the pharmacopoeial monographs

with the use of Pharmacopoeial Reference Standards.

23


26. I/we undertake that the decision of the Medical Superintendent ESIC MH Chandigarh regarding

inspection of Testing Facilities at Laboratory shall be final and will be binding on me and that I/we shall

not represent against the decision of the Medical Superintendent ESIC MH Chandigarh in any forum.

Yours faithfully

(Signature of bidder with stamp)

(Authorized Signatory)

Verification:

The undertaking given above is true to my knowledge and belief and signed inpresence of me

onthe day of _________ month of the Year ________.

(Signature of Notary with Full Name, date and stamp)

24


Annexure-“B”

PERSONNEL IN QC DEPARTMENT

Name of the

Technical staff

approved by State

licensing Authority

Since……..

Designation Qualification Experience (Experience

relevant to analysis of

Allopathic drugs )

Signature of Issuing Authority:

Date:

Name:

Designation:

Name of the Lab:

Office Seal:

LIST OF ALL FUNCTIONAL EQUIPMENTS/INSTRUMENTS/APPARATUS AVAILABLE IN

THE LAB AND FACILITIES IN THE MICROBIOLOGICAL SECTION

Sr.No. Name of the

equipment/Instrument

/Apparatus

Make and

Description

Date of

installation

Date of last

Validation

Approval for

testing of drugs

from State

licensing

Authority

Since……..

Signature with Name of Issuing Authority:

Date:

Designation:

Name of the Lab:

Office Seal:

25


Annexure “C”

Mandate form

Beneficiary’s detailsfor receiving payment through e-payment

1. Beneficiary name

2. Beneficiary address

3. Beneficiary account no.

4. Account type (S.B. Account/

current account for cash

credit) with code 10/11/13

5. 9 digit code number of the Bank &

branch appearing on the MICR cheque

issued by

6. Bank name

7. Bank name , Address, Telephone no.

8. IFSC (Indian financial service code)

9. Photocopy of cancelled cheque

I, hereby, declare that the particulars given above are correct and complete. If the transaction is delayed or

not effected at all for reason of incomplete or incorrect information given by me as above, I would not hold

the user institution responsible.

Dated ___________

(___________________________)

Signature of the beneficiary

Certified that the particulates furnished above are correct as per our records.

Bank’s stamp

Date ________________ (___________________________)

Signature of the authorized/official

26


Annexure “D”

Lowest Rate Certificate

(On Firm’s/Company’s Letter Head)

We hereby undertake that rates offered by me/us in the ESIC Rate Contract for Testing of Drugs are the

lowest rates offered to any Government organization/Autonomous Health Institution, and no other

Government organization/Institution has been offered rates lower than those being offered herein. We further

undertake that in case there is any down-ward revision, the same will be passed on to the ESIC MH

Chandigarh from the effective date during the currency of the contract and in case of failure to do so we are

liable to be debarred from future ESIC Tenders for a further period of two years along with forfeiting the

earnest money/security deposit.

(Signature of bidder with stamp)

(Authorized Signatory)

For and behalf of the firm

(Firm Name & Address)

27


Annexure-“E”

PRICE BID (Irrespective of Methodology used)

Table-I

1 2 3 4 5

Sr.No. Item No. Dosage Form Nameof Item Rate per Test (in Rupees)all

inclusive except GST

a) Rates quoted should be irrespective of methodology used and inclusive of Transportation

Charges/ Freight charges etc. exclusive of GST.

GST will be paid to the laboratory upon submission of claim to the ESIC MH Chandigarh

with proof of actual payment of GST.GST will be paid after deduction of TDS on GST as per

section 51 of GST Act.

b) If the bidder does not want to quote price for any item/drug, that item should not be

selected because the selected item cannot be left blank or quoted NIL/ZERO. If selected item

is left blank or quoted as nil/zero, the bidder stands disqualified for that item.

c) Price bid has to be submitted with exact serial number and exact item no.as per drug list

attached in Annexture G.

28


Annexure – “F”

CHECK LIST OF THE DOCUMENTS TO BE SUBMITTED WITH TECHNICAL BID

[ONLINE/HARD COPY WHICHEVER APPLICABLE]:

1) Hard Copy of Original Demand Draft of Rs.5,000/-(Rupees Five Thousand only) as EMD in

Favour of ESIC Fund Account No.1 payable at Chandigarh. (Soft copy also to be uploaded).

OR

Documents in support of the exemption of EMD. Validity of this document

should notexpire during the validity of Tender and during the entire duration

of contract if contract awarded after Technical and Financial bid evaluation.

2) Hard Copy of Affidavits as per clause 5, NB.- 5.1 (if applicable) under Instruction to bidders.

(Soft copy also to be uploaded).

3) Hard Copy of Advance pre-receipt affixing revenue stamp along with the full particulars of Bank

details in order to refund the EMD amount of unsuccessful bidders through ECS.(Soft copy also to

be uploaded).

4) Hard copy of Affidavit of the Laboratory on Non-Judicial stamp paper of Rs.100/-(As per

Annexure A)}.(Soft copy also to be uploaded).

5) Scanned Copies of BLANK Tender Document, duly signed & stamped by authorized signatory.

No offer of rates to be uploaded with Technical Bid.

6) Scanned copy of GST registration certificate.

7) Scanned copy of Valid License for carrying out “Testing Of Drugs & Dressings” issued from

Statutory Body, Authorized by Government of India with Approval under Drugs and Cosmetics

Act, 1940 and Rules, 1945 and amendments therein and should comply with schedule annexed

therein.

8) Scanned copy of valid accreditation from NABL for testing of drugsor valid certificate from

Competent authority of being a Governmentapproved laboratory for drugs testing.

9) Scanned copy of List of Government Institutions duly signed & stamped, to which Testing of

Drugs &Dressing Services are being provided by the Testing Laboratories on Bidder’s letter head.

10) Scanned copy of duly signed & stamped satisfactory performance certificate issued by the

Competent Authority of at least one (01) Government/Autonomous Institutions,on their letter head

of providing drug testing services for the last two consecutive years .

11) Scanned copy of List of Personnel in QC(Quality Control) department and List of important

equipments/instruments/apparatus in the lab and facilities in the Microbiological section. (Asper

Annexure B).

29

12) Scanned copy of Mandate Form as per Annexure C.

13) Scanned copy of undertaking (signed and stamped by tender signing authority) that the quoted

items have not been / are not being tested for any other organization at the rates lower than being

quoted here (As per Annexure D).

14) Scanned copy of Financial report indicating the annual turnover in Testing of

Drugs/dressings/vaccines etc. of not less than Rupees Ten lakhs per year of last three Financial

years (i.e. 2015-16, 2016-17, 2017-18,) duly attested by Chartered Accountant.

15) Scanned copy of any other Supportive document.

30

ANNEXURE - G List Of drugs

S. No.(Characters 5000 only )

Item No.(Characters 500 only )

Dosage Form(Characters 5000 only )

Name of Item (Characters 5000 only )

1 1 Syrup/Suspension

Antacid gel-200ml bottle, Each 5ml containing oxetacaine 10mg , Al. Hydroxide 291mg, Mag. Hydroxide 98mg

2 2 Tablet

Antacid tab containing Dried Aluminium Hydroxide 250mg , Magnesium Hydroxide 250mg, Methyl Polysiloxane /Activated Dimethicone 50mg

3 3 Injection Inj. Pantoprazole-40mg vial

4 4 Tablet Tab. Mesalamine/mesalazine-1.2gm (Enteric coated tablet)

5 5 Syrup/Suspension Laxative liquid-170ml bottle-Each 15ml containing Milk of Magnesia -11.25ml & liquid Paraffin-3.75ml

6 6 cream/ointment/gel Laxative Enema containing Glycerine 15% & sodium Chloride 15%-30ml bottle

7 7 Tablet Tab. Misoprostol-200 mcg

8 8 Tablet Tab. Misoprostol-25 mcg

9 9 Tablet Tab. Prucalopride-1mg

10 10 Tablet Tab. Metoclopramide-10mg

11 11 Syrup/Suspension Promethazine syp-100ml botts

12 12 Injection inj. ondansetron-4ml/8mg

13 13 Tablet Tab. Doxylamine succinate 10mg + Pyridoxine 10mg

14 14 Syrup/Suspension Ondansetron syrup -30ml botts (5ml=2mg)

15 15 Tablet Tab. Itopride-50mg

16 16 Tablet Tab. Mebeverine Hcl-135mg

17 17 Injection Inj. Drotaverine-2ml (each ml to contain Drotaverine-20mg)

18 18 Tablet Tab. Mefenamic acid-500mg

19 19 Tablet Tab. Otilonium Bromide-40mg

20 20 Tablet Tab. Ornidazole-500mg

31

21 21 Tablet

Each Film Coated tablet containing Metadoxine 500mg, silymarin 140mg,L-ornithine L-Aspartate 150mg, Pyridoxine Hcl-3mg, Folic Acid-1.5mg


Enzyme Drops- Each ml containing Alpha Amylase 20mg, Papain-10mg , Dill oil-2mg, Anise oil-2mg, Caraway oil-2mg-15ml phial


Enzyme syrup containing fungal diastase, cinnamon oil, caraway oil, cardamon oil, in glycerol sorbitol base-200ml botts

24 24 Tablet Tab. Sulphasalazine -500mg

25 25 Injection Inj. Tramadol-50mg per ml(2ml ampoule)

26 26 capsule Cap. Tramadol-50 mg

27 27 Tablet Tab. Tramadol-18.75mg + Acetaminophen 162.5 mg

28 28 Tablet Tab. Acetyl salicylic acid-75mg

29 29 capsule Cap. Indomethacin-25mg

30 30 Tablet Tab. Leflunomide-10mg

31 31 capsule Cap. Thiocolchicoside-4mg

32 32 Tablet Tab. Serratiopeptidase-5mg

33 33 Tablet Tab. Trypsin chymotrypsin

34 34 Injection Inj. Etanercept 50mg PFS/PFP

35 35 Eye drop-Eye Latanoprost Eye Drop-2.5ml vial containing 50mcg of Latanoprost

36 36 Injection Inj. Ranibizumab-10mg/ml-0.23ml vial

37 37 Ear Drop-Ear

Wax softner ear drops-10ml vial

containing Paradichlorobenzene,

benzocaine,chlorbutol,turpentine oil

38 38 Eye drop-Eye Bepotastine besilate opthalmic solution 1.5%w/v-5ml vial

39 39 Eye drop-Eye Bimatoprost 300mcg,Timolol Maleate 6.8mg equilant to Timolol 5mg

40 40 Eye drop-Eye Bimatoprost opthalmic solution 0.01 %-3ml vial

41 41 Eye drop-Eye

Lubricating Eye drop containing povidone 20mg/ml,preservative free,phosphate free-10ml vvial

32

42 42 Mouth Wash

Chlorhexidine Solution containing Chlorhexidine Gluconate 0.2% Solution-150ml bottle.

43 43 cream/ointment/gel

Metronidazole oral gel-20gm tube containing metronidazole 1% , chlorhexidine 0.25%


Paediatric cough syrup-60ml bottle – Each 5ml containing Promethazine 1.5mg, Pholcodine 1.5mg


Paediatric cough linctus syrup-50ml bottle-Each ml to contain Noscapine 1.83mg,citric acid-5.8mg, sodium citrate 0.67mg, Amm. Chloride 7mg

46 46 Inhaler-Inhaler Inhaler-200MDI-Each metered dose to contain levosalbutamol tartrate-50mcg

47 47 Inhaler-Inhaler

Inhaler to contain fluticasone propionate 250mcg + Formoterol fumarate 6mcg-120MDI

48 48 Respiratory Solution

Salbutamol respiratory solution-15ml bottle(each ml =salbutamol-5mg in normal saline)

49 49 Respiratory Solution

Ipratropium Respiratory solution -15ml bott (each ml=250mcg of ipratropium Br.)

50 50 Tablet Tab. Propranolol-40mg

51 51 Tablet Tab. Bisoprolol fumerate-5mg

52 52 Tablet Tab. Propranolol-10mg

53 53 Tablet Tab. Nicorandil-5mg

54 54 Injection Inj. Adenosine-6mg/2ml amp.

55 55 Tablet Tab. Ivabradine-5mg

56 56 Tablet/Capsule Tab./Cap Ranolazine-500mg

57 57 Tablet Tab. Prazosin SR-2.5mg

58 58 Tablet Tab. Prazosin SR-5mg

59 59 Injection inj. labetalol-4ml amp (each ml=5mg of labetalol Hcl)

60 60 Tablet Tab. Azilsartan medoxomil-40mg

61 61 Tablet Tab. Indapamide 1.5mg (as sustained release) + Amlodipine-10mg

62 62 Tablet Tab. Frusemide-40mg

63 63 Tablet Tab. Indapamide SR-1.5mg

64 64 Tablet Tab. Torsemide-20mg

65 65 Injection Inj. Tranexamic Acid-500mg amp

33

66 66 Tablet Tab. Tranexamic Acid 500mg + mefenamic acid-250mg

67 67 Topical Solution

Coagulant solution- Each ml to contain Aqueous solution of Haemocoagulase isolated from Bothrops Atrox or Bothrops Jararaca 0.2CU, Chlorhexidine Gluconate solution 0.1% (as preservative), water for injection q.s-10ml bott.

68 68 Injection Haemo-Coagulant inj.-1ml amp

69 69 Injection Inj. Heparin sodium 5000IU-5ml vial

70 70 Injection Inj. Dalteparin sodium-2500I.U

71 71 Injection Inj. Dalteparin sodium-5000 I.U

72 72 Tablet Tab. Cilostazol-100mg

73 73 Tablet Tab. Apixaban -2.5mg

74 74 Tablet Tab. Apixaban -5mg

75 75 Tablet Tab. Flunarizine-10mg

76 76 capsule Cap. fenofibrate-200mg (Micronised)

77 77 Tablet Tab. Diazepam-5mg

78 78 Tablet Tab. Phenobarbitone-30mg

79 79 Tablet Tab. Hydroxyzine hydrochloride-25mg


Syp. Phenobarbitone-60ml

bottle(each 5ml=20mg of phenobarbitone)

81 81 Syrup/Suspension Triclofos Syp-30ml bott. (5ml= Triclofos sodium 500mg)


Hydroxyzine Hydrochloride syrup-100ml bott .(Each 5ml= Hydroxyzine Hydrochloride 10mg)

83 83 Tablet Tab. Quetiapine-100mg

84 84 Tablet Tab. Nimodipine-30mg

85 85 Tablet Tab. Carbamazepin CR-200mg

86 86 Tablet Tab. Carbamazepin CR-400mg

87 87 Injection Inj. Phenytoin-2ml amp.

88 88 Tablet Tab. Tamoxifen-10mg

89 89 Injection Inj. Bleomycin-15units vial

90 90 Injection Inj. Doxorubicin-10mg -5ml vial

91 91 Injection Inj. Cisplatin-10mg vial

92 92 Injection Inj. Cisplatin-50mg vial

93 93 Tablet Tab. Tamoxifen-20mg

94 94 Injection Inj. Docetaxel-80mg

95 95 Injection Inj. Epirubicin hydrochloride-50mg vial

34

96 96 Tablet Tab. Deferasirox-100mg

97 97 Tablet Tab. Deferasirox-400mg

98 98 Injection Inj. Bevacizumab-100mg vial

99 99 Injection Inj. Trastuzumab-440mg vial

100 100 Injection Inj. Leuprolide-3.75mg PFS/Vial

101 101 Injection Inj. Leucovorin-50mg vial

102 102 Injection Inj. oxaliplatin-50mg vial

103 103 Injection Inj. Zoledronic Acid-4mg vial

104 104 capsule

Each hard gelatin capsule contains Alectinib 150mg equivalent to Alectinib hydrochloride 161.3mg

105 105 Injection Inj. Atezolizumab-1200mg-20ml vial

106 106 Tablet Tab. Tofacitinib citrate-5mg

107 107 Injection Adalimumab injection 20mg/0.4ml-PFS

108 108 Injection inj. Ifosfamide-1gm vial

109 109 Injection Inj. Docetaxel lipid suspension 80mg-vial

110 110 Injection Inj. Nivolumab 100mg/10ml vial

111 111 IV Fluids-Injection Inj. Paracetamol-IV-50ml-500mg

112 112 Injection Adalimumab injection 40mg/0.8ml-PFS

113 113 Injection Inj. Irinotecan 100mg-5ml vial

114 114 Injection Inj. Pemetrexed 100mg -vial

115 115 Injection Inj. Azacitidine 100mg -vial

116 116 Injection Inj. Fulvestrant-250mg vial

117 117 Injection Inj. Docetaxel lipid suspension 20mg-vial(nanosomal Lyophilized)

118 118 Injection Inj. Degarelix-80mg -vial

119 119 Injection Inj. Trastuzumab-150mg vial

120 120 Injection Inj. Irinotecan 40mg-2ml vial

121 121 Tablet Tab. Tacrolimus-2mg

122 122 IV Fluids-Injection

Peritoneal Dialysis fluids 1.5 % containing dextrose 1.5gm, sodium lactate 448mg, Nacl 538mg, Ca cl 25.7mg, Mgcl 5.08mg per 100ml-2ltr bag


Peritoneal Dialysis fluids2 .5 % containing dextrose 2.5gm, sodium lactate 448mg, Nacl 538mg, Ca cl 25.7mg, Mgcl 5.08mg per 100ml-2ltr bag

35

124 124 Tablet Tab. Tenofovir Alafenamide

25mg

125 125 Tablet Tab. Norethisterone 5mg

126 126 Tablet/Capsule Tab/cap. Danazol-100mg

127 127 Tablet/Capsule Tab./Cap. Danazol-200mg

128 128 Tablet Tab. Medroxy progesterone-10mg

129 129 Injection Inj. Noradrenaline-2ml amp.

130 130 Injection Inj. Medroxy-Progesterone Acetate-150mg

131 131 Injection Inj. Medroxy-progesterone acetate suspn.-150mg-1ml vial

132 132 Tablet Tab. Levonorgestrel -75mg

133 133 Tablet Tab. Clomiphene citrate -50mg

134 134 Tablet Tab. Methylprednisolone -16mg

135 135 Tablet Tab. Methylprednisolone -4mg

136 136 Tablet Tab. Carbimazole-5mg

137 137 Injection Inj. Insulin glargine-3ml vial-100 units/ml

138 138 Injection Inj. Insulin Glargine-10ml vial-100 units/ml

139 139 Injection

Inj. Insulin Glargine-3ml cartridge-Each ml to contain 100 units insulin glargine

140 140 Injection

Inj. Insulin Glulisine -10ml vial-Each ml to contain insulin glulisine 100IU,m-cresol-3.15mg excipient q.s

141 141 Injection

Inj. Insulin Glulisine -3ml cartridge -Each ml to contain insulin glulisine 100IU,m-cresol-3.15mg excipients q.s

142 142 Tablet/Capsule Tab./Cap. Cefaclor-250mg

143 143 Tablet Tab. Cefditoren pivoxil 200mg


Ampicillin dry syrup-30ml bottle-Each 5 ml to contain Ampicillin 125mg


Cephalexin syrup-30ml bottle- Each 5ml to contain 125mg cephalexin 125mg

146 146 Syrup/Suspension Cefixime Dry Syrup-30ml bottle -Each 5ml to contain cefixime 50mg

147 147 Tablet Tab. Nevirapine-200mg

36

148 148 capsule Cap. Ribavirin-200mg

149 149 Tablet Tab. Entecavir-0.5mg

150 150 Tablet Tab. Entecavir-1mg

151 151 Injection Inj. Propofol-1%-10ml vial

152 152 Injection Inj. Bupivacaine Hcl-0.25%-20ml vial

153 153 Injection

Inj. Atracurium besylate -2.5ml Amp. -Each ml to contain Atracurium besylate-10mg

154 154 Injection Inj. Fentanyl-2ml amp. -Each ml to contain Fentanyl 50mcg

155 155 Tablet Tab. Flavoxate Hydrochloride-200mg

156 156 Injection Inj. Carboprost-0.25mg-1ml amp.

157 157 Vaginal Tablet Clotrimazole vaginal tablet-200mg

158 158 cream/ointment/gel Clotrimazole vaginal gel-2% w/w

159 159 Tablet Tab. Pheniramine Maleate 25mg

160 160 Tablet Tab. Dexchlorpheniramine SR-6mg

161 161 Tablet Tab. Ebastine-20mg


Ointment containing salicylic acid 6% w/w, Benzoic acid 12% w/w, Hydrocortisone Acetate 0.5% w/w-15gm tube

163 163 cream/ointment/gel Miconazole Nitrate 2% Cream-15gm tube


Antifungal gel-15gm tube containing Adapalene 0.1% w/w, Clindamycin phosphate USP 1% w/w

165 165 Powder-Dusting powder Clotrimazole dusting powder 1% w/w-75gm


Cream containing Urea 12% w/w, lactic acid 6% w/w,Ammonium Chloride 0.5% w/w, sodium chloride 0.5% w/w, potassium chloride 0.5% w/w, calcium lactate 0.5% w/w, Magnesium chloride 0.3% w/w, sodium Dihydrogen phosphate 0.5& w/w -50gm jars

167 167 cream/ointment/gel Feracrylum With Centbucridine Hydrochloride gel-20gm tube

168 168 cream/ointment/gel Permethrin 5% Cream-30gm tube

169 169 Lotion Minoxidil 2% lotion-60ml bottle

170 170 Lotion Minoxidil 5% lotion-60ml bottle

37


Ointment containing Silver sulphadiazine 1%,Chlorhexidine Gluconate 0.2%, Aloe Vera 15%, Allantoin 0.1%, Vitamin E 0.2%-15gm tube

172 172 cream/ointment/gel Metronidazole 1% + Povidone Iodine 5% ointment-15gm tube

173 173 cream/ointment/gel Fusidate Sodium Ointment-5gm tube

174 174 Lotion Sertaconazole Nitrate Lotion -2% w/v-15ml phial

175 175 cream/ointment/gel Benzoyl Peroxide Gel 2.5%-20gm

176 176 cream/ointment/gel Mupirocin 2% w/w, Beclomethasone Dipropionate 0.025% w/w-5gm

177 177 cream/ointment/gel Clobetasol Ointment 0.05% -10gm tube

178 178 cream/ointment/gel Clobetasol propionate 0.05% w/w, salicylic acid 6% w/w-10gm tube

179 179 cream/ointment/gel Tretinoin Cream 0.05%-20gm tube


Hydroquinone 4% w/w, Tretinoin 0.025% w/w, Mometasone furoate 0.1%w/w-30gm tube

181 181 cream/ointment/gel Adapelene Gel-0.1%-15gm tube

182 182 Topical Solution Coal Tar 4.25% + Salicylic Acid 2% solution-60ml bottle

183 183 Dressing material

Feracrylum 3% Dressing -pouch of 10cm x 10cm- Gauze Dressing sterile, cotton dressing impregnated with water soluble base.

184 184 Lotion Calamine Lotion -100ml bottle containing Calamine 15%, zinc oxide 5%

185 185 capsule

Multivitamin Cap containing Ferrous fumerate 30mg, folic acid 250mcg, zinc sulphate 20mg, Thiamine mononitrate 1.2mg, Riboflavin 1.2mg, Niacinamide 10mg,pyridoxine 1mg, cyanocobalmin 2.5mcg, Ascorbic acid-40mcg

38


Vitamin B Complex syrup-200ml bottle-Each 5ml to contain Vit.A 2500IU, Cholecalciferol 200IU, Thiamine 2mg, Riboflavin 1mg, Pyridoxine 1mg, Nicotinamide 15mg,Ascorbic acid 50mg, D-Panthenol 2.5mg, Cyanocobalamin 1mcg,Citrus Bioflavonoid compound 5mg

187 187 Liquid preparation

Potassium Chloride liquid-200ml-each 15ml to contain Potassium Chloride 1.5gm


Calcium Syrup-200ml bottle -each 5ml to contain Vitamin D3 200IU, Vit. B12 2.5mcg, Calcium 82mg

189 189 capsule

Iron & vitamin cap to contain Ferrous fumarate 350 mg, Vit.C 150mg, Vit. B12-15mcg, Folic Acid-1.5mg

190 190 Tablet

Each film coated tablet to contain ferrous ascorbate equivalent to elemental iron 100mg, folic acid 1.1mg +Mecobalamine 1.5mg + zinc sulphate monohydrate equivalent to elemental zinc 22.5mg

191 191 Injection

Each 2ml amp contains

Mecobalamine 1500mcg,

Pyridoxine Hydrochloride 100mg, Nicotinamide 100mg,

Benzyl alcohol IP 2% v/v

192 192 capsule

Each Cap contains calcium carbonate 500mg, calcitriol 0.25mcg, mecobalamine 1500mcg,, eicosapentaenoic acid 90mg, docosahexaenoic acid 60mg, folic acid 400mcg, Disodium tetraborate equivalent to elemental Boron 1.5mg

193 193 Tablet

Each film coated tablet to contain calcium aspartate 500mg, calcium orotate 500mg, calcitriol 0.25mcg, zinc (as zinc sulphate monohydrate IP 7.5mg, magnesium hydroxide IP 50mg, hydroxocobalamine IP 100mcg, folic acid IP 1.5mg, Excipients q.s

39

194 194 Tablet

Each tablet to contain Atorvastatin calcium equivalent to atorvastatin 10mg + Methylcobalmine 500mcg + Folic acid IP 5mg +Pyridoxine Hcl IP 10mg

195 195 capsule

Each soft gelatin capsule containing Ginseng extract 43.5mg, Niacinamide 25mg, vitamin B6 1mg, Mecobalamine, vitamin D3, Folic acid, Calcium Phosphate, Ferrous fumerate, Zinc sulphate, Magnesium sulphate,, copper sulphate, potassium iodide, potassium sulphate

196 196 Syrup/Suspension Haematinic with amino acid , vitamin and zinc syrup-200ml bottle

197 197 Tablet/Capsule

Antioxidant cap./tab.- Containing carotenoid & micronutrients from carrots

198 198 Injection Inj. Erythropoietin 3000 units-PFS


Iron + Vitamin Syp-200ml bottle -Each 5ml to contain Collodial iron eqv. To elemental iron 250mg, folic acid 500mcg, vitamin B12-5mcg

200 200 Drops-Oral Drops

Iron & folic acid drop -15ml vial-each ml containing colloidal iron eqv. to elemental iron 25mg, lysine hydrochloride 200mg, vitamin B12-5mcg, folic acid 200mcg,

201 201 Injection

Aflibercept injection 40 mg / mlAflibercept (r-DNA Origin) solution for intravitreal injection in VialEach pack contains: 1 vial and a 18 G Sterile filter needle 278 microliters/vial Each single dose vial provides a usable amount to deliver a single dose of 50 microliters containing 2mg Aflibercept

202 202 capsule

Each cap contains : 143 mcg indacaterol maleate eqv. to 110 mcg indacaterol & 63 mcg Glycopyrronium Bromide eqv to 50 mcg Glycopyrronium.

203 203 Injection FONDAPARINUX SODIUM INJ Each PFS to contain: fonfaparinux sodium 2.5 mg

40

204 204 Tablet

Each film coated tablet contains micronised - purified flavonoid fraction 1000mg composed of diosmin 900mg (90%) and flavonoids expressed as hesperidin 100mg (10%)

205 205 Inj-PFS Hemostat containing: Hemostatic matrix with thrombin in prifilled syringe 10ml

206 206 Injection TENECTEPLASE 40MG INJ - Each vial to contain: Tenecteplase 40mg

207 207 Injection CYTOSINE ARABINOSIDE INJ - Each vial to contain: Cytosine Arabinoside 100mg.

208 208 Tablet/Capsule

APREPITANT TAB/CAP - Each pack to contain: Aprepitant (125 mg one tab/cap and 80 mg two tab/cap)

209 209 Injection RASBURICASE INJ - Each vial to contain: Rasburicase 1.5 mg

210 210 Injection HUMAN ALBUMIN 20% INJ - Each bot to contain: Human Albumin 20%

211 211 Tablet

Each film coated tablet to contains Pazopanib Hydrochloride equivalent to 400mg Pazopanib

212 212 Tablet

Each film coated tablet to contains:Eltrombopag Olamine equivalent to 25mg of eltrombopag as eltrombopag free acid

213 213 Tablet

Each film coated tablet to contains:Eltrombopag Olamine equivalent to 50mg of eltrombopag as eltrombopag free acid

214 214 Injection

Each Single dose vial contains:(Sterile lypholized) Triptorelin Pamoate equivalent to Triptorelin 11.25mg Pamorelin LA 11.25 Inj.

215 215 Injection Each vial to contains Denosumab 120 mg (70mg/ml) Total fill 1.7ml in 5ml vial

216 216 Injection Each Single use vial of 5 ml contains Panitumumab 100 mg (20mg/ml)

217 217 capsule Palbociclib Capsules Each hard gelatin cap contains : Palbociclib 125mg

41

218 218 Injection Each vial to contains : ado-trastuzumab emtansine 160mg

219 219 Injection Each vial to contains : ado-trastuzumab emtansine 100mg

220 220 Tablet Each tab to contains: Afatinib 40 mg

221 221 Tablet Each Tab to contains:Regorafenib 40mg

222 222 Tablet Each tab to contain: Abiraterone acetate 250 mg

223 223 Injection

Inj Recombinant Human Granulocyte Macrophage Colony stimulatingFactor (r-hu-GMCSF) 500microgram

224 224 Injection

Ramucirumab Concentrate for Solution for InfusionEach vial contains : Ramucirumab 500mg / 50ml vial component :Ramucirumab 500mgL-Histidine 32.5mgL-Histidine Monohydrochloride 61.0mg Glycine 499mgSodium Chloride 219mgPolysorbate -80 5.0mg Water for Injection q.s

225 225 Injection

Each 1 ml conatins: Secukinumab 150mg Sucrose 92.43mg L- Histidine / L- Histidine MCL Monohydrate 4.656 mg Polysorbate 80 - 0.60mg.

226 226 Injection

Golimumab (r-DNA origin) Each single use Pre-Filled Syringe contians : Golimumab 50mg/0.5ml Component [amount per dose (mg)]: Golimumab (CNTO 148) -50mg, Sorbitol -20.5mg, L-Histidine -0.44mg, Polysorbate 80 - 0.075mg Water for Injection - 0.5mg

227 227 Topical Solution

Heparin Topical Solution 1000 IU/ml Each ml contains : Heparin Sodium IP 1000 IU Absolute Alcohol IP 10% V/V


LOW CALCIUM CAPD - Each to contain: CAPD Bags with 1.5% concentration containing 40 mEq/litre of lactate and 2.5 mEq/litre of Ca with asymmetrical Y connector

42


LOW CALCIUM CAPD - Each to contain: CAPD Bags with 2.5% concentration containing 40 mEq/litre of lactate and 2.5 mEq/litre of Ca with asymmetrical Y connector

230 230 Injection-Vaccine

HUMAN TETANUS SPECIFIC IMMUNOGLOBULIN - Each vial to contain: Human Tetanus Specific Immunoglobulin 500 units.


HEPATITIS B IMMUNOGLOBULIN INJ - Each 1ml to contain:Inj. Hepatitis B Immunoglobulin 200 IU


IMMUNOGLOBULIN - Each to contain: Rho (D) Immune Globulin (Human) 1500 IU.(300mcg)

233 233 Injection

IMMUNOGLOBULIN - Each 1 ml solution contain : Active substance(s) Human plasma proteins 50 mg, IgM 6 mg (12%) , IgA 6 mg (12%) IgG 38 mg (76%)


ANTI RABIES VACCINE - Each ml to contain : HRG (Rabies Immunoglobulin (Human)) 150IU

235 235 Injection

HUMAN TETANUS SPECIFIC IMMUNOGLOBULIN - Each vial to contain: Human Tetanus Specific Immunoglobulin 250units.


Meningococcal Group (A,C,Y and W135) Polysachharide Diphtheria Toxoid Conjugate Vaccine


Snake Anti venin (Polyvalent) IP 10ml (Enzyme refined Equine Globulins) Each 1ml neutralises: 0.60mg of Cobra venom (Naja Naja), 0.45mg of Common Krait Venom(Bungarus Caeruleus), 0.60mg of Ruseells Viper Venom (Vipera russelli), 0.45mg of Saw scaled Viper Venom (Echis carinatus) Preservatives Phenol IP 50.25% w/v

238 238 Injection

Each vial to contains: Recombinanant Follicle Stimulating Hormone or r-FSH (Follitrophine Beta) 100 IU/0.5 mL soln. for Inj.

43

239 239 Injection

HUMAN CHORIONIC GONADOTROPIN INJ - Each ml to contain: Human Chorionic Gonadotropin 2000 IU

240 240 Injection

HUMAN CHORIONIC GONADOTROPHIN INJ - Each ml to contain : Human Chorionic Gonadotrophin 10000 IU

241 241 Tablet

Each film coated tab to contains Canagliflozin hemyhydrate equivaltent to Canagliflozin 100mg

242 242 Tablet Empagliflozin Tab: Each film coated tab to contains: Empagliflozin 10 mg

243 243 Injection INSULIN ASPART INJ - Each vial to contain: Insulin Aspart (R-DNA origin)

244 244 Injection

BIPHASIC INSULIIN ASPART INJ - Each penfill to contain: Biphasic Insulin Aspart (R-DNA origin)

245 245 Injection

INSULIN DETEMIR INJ - Each inj to contain: Insulin Detemir 100 IU/ml (R-DNA)

246 246 Injection

INSULIN INJ - Each Cartridge to contain: 25% Lispro and 75% Lispro Protamine Suspension (100 IU/mL) [Monocomponent Insulin, recombinant DNA origin]

247 247 Injection

INSULIN INJ - Each Cartridge to contain: 50% Lispro and 50% Lispro Protamine Suspension (100 IU/mL) [Monocomponent Insulin, recombinant DNA origin]

248 248 Injection

INSULIN DEGLUDEC INJ - Each 1ml of the solution for subcutaneous inj to contain: Insulin Degludec (R-DNA origin) 100 unit/ml Pre Filled Pen

249 249 Injection CASPOFUNGIN ACETATE INJ - Each vial to contain: Caspofungin Acetate 50mg

250 250 Injection

HUMAN INTERFERON BETA 1A INJ - Each PFS/vial to contain: Recombinant Human Interferon Beta1a 44mcg

251 251 Injection ROCURONIUM INJ - Each ml. to contain: Rocuronium 10mg.

44


TRIPLE CHAMBER BAG - Each to contain: Triple Chamber Bag with Lipid Emulsion (80% Olive Oil & 20% Soya Oil), Amino Acids, Glucose and Electrolytes separated by peel seals for Peripheral intravenous


TRIPLE CHAMBER BAG - Each to contain: Triple Chamber Bag with Lipid Emulsion (80% Olive Oil & 20% Soya Oil), Amino Acids, Glucose and Electrolytes separated by peel seals for Central Intravenous.

254 254 Tablet/Capsule SOFOSBUVIR 400 MG TAB/CAP - Each Tab/Cap to contain : Sofosbuvir 400 mg

255 255 Injection

FERRIC CARBOXY MALTOSE EQV. TO ELEMENTAL IRON 50MG INJ - Each ml to contain: Ferric Carboxy Maltose eqv. To Elemental Iron 50mg

256 256 Injection

DARBEPOETIN ALFA 40 MCG/0.4ML INJ - Each PFS to contain: Darbepoetin Alfa 40 mcg/0.4ml

257 257 Injection

ERYTHROPOIETIN INJ - Each pack to contain: Recombinant Human Erythropoietin 10000 units

258 258 Sachet

Antacid Sachet containing water soluble Azulene JPC2.01 mg L-Glutamine JPC 663.3mg

259 259 Tablet Tab. Euphorbia Prostrata

260 260 Injection Inj. Omalizumab-150mg

261 261 Spacer Device Spacer Device-spacer suitable for MDI inhaler of all brand

262 262 Injection Human Coagulation Factor VII (r-DNA origin)Inj.-1mg vial

263 263 Injection Human Coagulation Factor VII activated (r-DNA origin) inj-2mgvial

264 264 Injection Factor Eight Bypassing Activity,Anti-Inhibitor-Coagulant complex-500IU-vial

265 265 Injection Recombinant Anti Hemophillic Factor -VIII-250IU-Pack


45


268 268 Injection Inj. AntiHemophillic Factor VIII Monoclonal Purified-250IU

269 269 Injection Inj. Anti Hemophillic IX-600IU-vial

270 270 Injection Inj. Streptokinase-7.5lac IU-vial

271 271 Injection Inj. Enoxaparin20mg/0.2ml

272 272 Injection Inj. Enoxaparin 60mg/0.6ml -PFS

273 273 Injection Inj.Sodium Hyaluronate (Intra Articular)-1 PFS-2.5ml/PFS-25mg

274 274 Injection Inj. Hylan G-F20 -6ml PFS

275 275 Injection Inj. Tocilizumab -80mg

276 276 Injection Inj. Tocilizumab-200mg

277 277 Injection Inj. Tocilizumab-400mg

278 278 Injection

Human Growth Hormone containing Somatropin 18IU (R-DNA Origin)-1 cartridge

279 279 Injection Human Growth Hormone containing Somatropin 4IU (R-DNA Origin)-1VIAL

280 280 Injection

Human Growth Hormone containing somatropin 16IU(R-DNA origin)-1 cartridge


Human Epidermal Growth -each one gm to contain 150mcg of recombinant human epidermal growth factor gel-7.5gm tube

282 282 Injection

Somatropin (R-DNA)Inj.-Each PFS contain somatropin (r-DNA)origin Bio Synthetic human growth hormone solution 10mg/1.5ml=30iu

283 283 Injection Follitropin Alpha 1050IU/1.75ml inj-vial

284 284 Injection Inj. Human Chorionic Gonadotropin -5000IU-1ml vial

285 285 Injection

Human Insulin Mixed (50% + 50%)-containing human Insulin 50% Soluble + 50% NPH 40units/ml-10ml

286 286 Injection

Human Insulin Biphasic Mixed (30 %+70 %)-each vial to contain : human insulin biphasic 30% soluble +70% NPH 40units/m-10ml vial

46

287 287 Injection

Liraglutide Inj. - inj. Human GLP-1 analogue contains Liraglutide 6mg/ml-3ml

288 288 Injection

Insulin Lispro Inj.-Each Cartridge contain: Insulin Lispro(100IU/ml)(monocomponent insulin,recombinant DNA origin)-3ml

289 289 Injection Inj. Interferon Beta 1-A-0.5ml PFP-30mcg(6 million IU)

290 290 Injection Inj. Erythropoietin 20,000 units

291 291 IV Fluids-Injection Amino Acid (for IV Infusion)-200ml glass bottle

292 292 Injection Inj. Pemetrexded Disod-500mg

293 293 Injection Inj. Rituximab-100mg

294 294 Injection Inj. Rituximab-500mg

295 295 Injection Inj. Paclitaxel-300mg

296 296 Injection Inj. Filgrastim-300mcg-vial

297 297 Tablet Tab. Everlimus 0.25mg

298 298 Tablet Tab. Everlimus -0.5mg

299 299 Tablet Tab. Everlimus-0.75mg

300 300 Injection Inj. Octreotide -30mg long acting release-vial

301 301 Injection Inj. Bortezomib-1mg-vial

302 302 Injection Inj. Bortezomib-3.5mg-vial

303 303 Injection Inj. Paclitaxel-200mg

304 304 Injection Inj. Asparaginase-10,000units

305 305 Injection-Contrast Media

Non Ionic Contrast Media; Each ml to contain : Iohexol 647mg eqv. To Iodine 300mg


Hepatitis B Vaccine (R-DNA)-10ml vial -Each ml. to contain 20mcg of Hepatitis B surface Antigen


Hepatitis B Vaccine (R-DNA)-vial -Each Vial to contain 20mcg of Hepatitis B surface Antigen

308 308 Injection-vaccine

Hepatitis B Vaccine (R-DNA)-1 vial-Each Vial to contain 10mcg of Hepatitis B Surface antigen

309 309 Injection-Vaccine Tetanus Vaccine (Adsorbed)-0.5ml amp. Containing Tetanus Toxoid 5/LFS

310 310 Injection Inj. Erythropoietin 2000 units

311 311 Iv Fluids-Injection Plasma volume Expander-500ml

47

312 312 Eye ointment

POLYMIXIN, NEOMYCIN EYE OINT. - containing per gm. Polymixin B Sulphate 5000 IU Neomycin sulphate 3400 IU Zinc Bacitracin 400 IU

313 313 Tablet Each Tab to contains:Ticagrelor 90mg

314 314 Tablet Each Film Coated tab contain: Ivabradine hcl equivalent to Ivabradine7.5mg

315 315 Tablet Each film coated tablet contains: 24mg sacubitril and 26mg valsartan as sodium salt complex

316 316 Tablet Each film coated tablet contains: 49mg sacubitril and 51mg valsartan as sodium salt complex

317 317 Tablet HAEMOSTATIC TAB - Each tab. to contain: Micronized purified Flavonoid fraction of Rutaceae 500mg

318 318 injection HAEMOSTATIC - Each 5ml to contain: Haemostatic Matrix with Prefilled Gelatin Granules in Syringes

319 319 capsule Dabigatran Cap: Each Cap to contains: Dabigatran Etexilate 110 mg

320 320 injection ANTICOAGULANTS-Each Kit to contain:Two componant fibrin sealant with synthetic Aprotinin (4ml)

321 321 injection INFLIXIMAB INJ - Each vial to contain: Infliximab 100mg.

322 322 Tablet DASATINIB TAB - Each tab to contain: Dasatinib 20mg



325 325 Tablet CAPECITABINE TAB - Each tab to contain: Capecitabine 500mg

326 326 Tablet/capsule SUNITINIB MALATE TAB/CAP - Each tab/cap to contain: Sunitinib Malate 25mg

327 327 injection DECITABINE INJ - Each vial to contain: Decitabine – 50mg

328 328 Tablet SORAFENIB TAB - Each tab to contain: Sorafenib Tosylate 200mg.

48

329 329 Tablet VALGANOCICLOVIR TAB - Each tab to contain:Valganociclovir 450mg

330 330 injection PACLITAXEL INJ - Each vial to contain: Paclitaxel 260mg

331 331 injection FILGRASTIM INJ - Each PFS/Vial to contain: Filgrastim 150 mcg

332 332 injection GOSERELIN INJ - Each PFS to contain: Goserelin 3.6mg.

333 333 capsule Each hard gelatin capsule to contains: Ceritinib 150mg

334 334 Tablet/capsule Each cap/tab to contain : Ibrutinib 140mg.

335 335 Tablet Each tablet to contains Ruxolitinib 15mg

336 336 Tablet Each tablet contains Ruxolitinib 20mg

337 337 Tablet Each tablet contains Ruxolitinib 5mg

338 338 injection Each vial to contains: Obinutuzumab 1000 mg

339 339 injection Each 4 mL vial to contains: Nivolumab 40mg (40mg/4 mL)

340 340 injection Each 14ml vial to contain : Pertuzumab 420mg (30mg/ml)

341 341 capsule Crizotinib Capsules Each Hard Geletin Cap. contains : Crizotinib 250mg

342 342 injection Each vial to contains: Carfilzomib 60mg sterile lypholized powder



345 345 Tablet Each film coated tab to contains: Axitinib 5 mg

346 346 injection Each vial to contains:Trabectedin 1 Mg

347 347 Tablet Each tab to contain:Erlotinib 150 MG

348 348 injection Each vial to contains: Bendamustine HCL 100mg

349 349 Tablet Each Tab to contains: Everolimus 05 mg

350 350 Tablet DYDROGESTRONE TAB - Each tab to contain : Dydrogestrone I.P./U.S.P.10 mg.

351 351 Tablet CABERGOLINE TAB - Each tab to contain:Cabergoline 0.5mg.

352 352 Tablet Dapagliflozin: Each Tab. to contains Dapagliflozin 5mg

49

353 353 Tablet SAROGLITAZAR tab: Each uncoated tab to contains: Saroglitazar 4 mg

354 354 injection TEICOPLANIN INJ - Each vial. to contain :Teicoplanin400mg.

355 355 injection COLISTIMETHATE SODIUM INJ - Each vial to contain: Colistimethate Sodium BP 10,00,000 I.U.

356 356 injection LIPOSOMAL LYOPHILIZED B INJ: Each vial to contain liposomal amphotercin BP 50 MG(LYOPHILIZED)

357 357 injection ISOFLURANE - Each 100ml to contain: Isoflurane

358 358 injection SEVOFLURANE INJ - Each 250ml to contain: Sevoflurane

359 359 Injection-fluids

POLYMER OF DEGRADED GELATIN ( FOR IV INFUSION) Each to contain : polymer of degraded gelatin 3.5 gm. Electrolytes & distilled water to 100 ml per 100 ml

360 360 injection Inj. Palonosetron Hydrochloride-1.5ml

361 361 Tablet Tab. Racecadotril dispersible -10mg

362 362 Tablet Tab. Rececadotril dispersible-30mg

363 363 cream/ointment/gel Haemorrhoidal Cream-30gm tube containing Euphorbia Prostrata

364 364 capsule Cap. Essential Phospholipids 300mg & Hydroxyethyl Theophylline -50mg

365 365 Tablet Tab. Garenoxacin-200mg

366 366 inhaler Tiotropium Bromide 9mcg inhaler-120doses

367 367 Rotahaler device Rotahaler Device

368 368 injection Inj. Urokinase- 5 lakh IU

369 369 Tablet Tab. Tolperisone HCL-150mg

370 370 Tablet Tab. Tolperisone HCL-150 mg & Diclofenac Sodium-50mg

371 371 Transdermal patches

Buprenorphine Transdermal Patch-Each Transdermal patch to contain : Buprenorphine 5mcg/hr. Area containing active substance-6.25 sqcm- patch

50


Buprenorphine Transdermal Patch-Each Transdermal patch to contain : Buprenorphine 10mcg/hr. Area containing active substance-12.5 sqcm -patch


Buprenorphine Transdermal Patch-Each Transdermal patch to contain : Buprenorphine-20mcg/hr. Area containing active substance-25 sqcm patch

374 374 injection Inj.Teriparatide-750mcg-cartridge

375 375 injection Inj. Teriparatide 600mcg-PFP

376 376 Tablet Tab. Conjugated Oestrogen-0.625mg

377 377 injection Inj. Ertapenam Sodium-1gm vial

378 378 injection Inj. Teicoplanin-200mg

379 379 injection Inj. Tigecycline -50mg

380 380 injection Inj. Amphotericin-B-50mg

381 381 injection Inj. Streptomycin-0.75gm-1 vial

382 382 injection Inj. Iron Sucrose-5ml amp.

383 383 Injection-fluids Intravenous Lipid Solution 20% -250ml

384 384 injection Inj. Epirubicin Hydrochloride-10mg

385 385 injection Inj. Nimotuzumab-50mg

386 386 capsule Cap. Sunitinib Malate-12.5mg

387 387 capsule Cap. Sunitinib Malate-50mg

388 388 Tablet Tab. Sevelamer-400mg

389 389 Tablet Tab. Bicalutamide-50mg

390 390 injection Inj. Fludarabine-50mg

391 391 injection Inj. Mitomycin-10mg vial

392 392 injection Inj. Methotrexate-50mg -vial

393 393 injection Inj. Peg-Filgrastim 6mg/ml-1ml PFS

394 394 injection Inj. Paclitaxel-30mg vial

395 395 capsule Cap. Lenalidomide-5mg

396 396 Injection-Vaccine Polysaccharide Pneumococcal vaccine -0.5ml vial

Total No. of items=396 (Three hundred ninety six only)